David E. Wheadon
Impact in
-
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Pharmacology top 10%
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Obsessive-Compulsive Spectrum Disorders 3
- Suicide and Self-Harm Studies 2
-
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 3
- Co-authors
- Martin Steiner (3 shared papers)Ivan P. Gergel (4 shared papers)James C. Ballenger (1 shared paper)Daniel N. Masica (3 shared papers)Daniel B. Burnham (3 shared papers)Andrea Allen (1 shared paper)Eric Hollander (1 shared paper)Robert L. Zerbe (1 shared paper)
- Journals
- Journal of Affective Disorders (2 papers)American Journal of Psychiatry (2 papers)European Neuropsychopharmacology (2 papers)New England Journal of Medicine (1 paper)European Psychiatry (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
David E. Wheadon
12 papers receiving 417 citations
Peers
Comparison fields: 5 of 44
- Experimental and Cognitive Psychology 144
- Pharmacology 116
- Clinical Psychology 153
- Behavioral Neuroscience 15
- Psychiatry and Mental health 67
Countries citing papers authored by David E. Wheadon
This map shows the geographic impact of David E. Wheadon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Wheadon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Wheadon more than expected).
Fields of papers citing papers by David E. Wheadon
This network shows the impact of papers produced by David E. Wheadon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Wheadon. The network helps show where David E. Wheadon may publish in the future.
Co-authors
The 20 scholars most cited alongside David E. Wheadon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 170 | |
| 2 | 2003 | 112 | |
| 3 | 1993 | 70 | |
| 4 | 1992 | 30 | |
| 5 | Lack of association between fluoxetine and suicidality in bulimia nervosa. | 1992 | 26 |
| 6 | 1982 | 20 | |
| 7 | 1995 | 20 | |
| 8 | 1988 | 16 | |
| 9 | A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period. | 1995 | 15 |
| 10 | 1996 | 10 | |
| 11 | 1995 | 6 | |
| 12 | 2010 | 5 |
About David E. Wheadon
David E. Wheadon is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology, Psychiatry and Mental health, Behavioral Neuroscience and Toxicology, having authored 12 papers that have together received 500 indexed citations. Recurring topics across this work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Obsessive-Compulsive Spectrum Disorders (3 papers), Suicide and Self-Harm Studies (2 papers), Medicinal Plant Extracts Effects (1 paper), Treatment of Major Depression (1 paper), Schizophrenia research and treatment (1 paper), Electroconvulsive Therapy Studies (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Experimental and Cognitive Psychology (144 citations), Pharmacology (116 citations), Clinical Psychology (153 citations), Behavioral Neuroscience (15 citations) and Psychiatry and Mental health (67 citations). David E. Wheadon has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Martin Steiner, Ivan P. Gergel, James C. Ballenger, Daniel N. Masica, Daniel B. Burnham, Andrea Allen, Eric Hollander, Robert L. Zerbe, John H. Heiligenstein and Charles M. Beasley. Their work appears in journals such as Journal of Affective Disorders, American Journal of Psychiatry, European Neuropsychopharmacology, New England Journal of Medicine and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.